Nixon Peabody LLP

  • People
  • Capabilities
  • Insights
  • About

Trending Topics

    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni

    Practices

    View All

    • Affordable Housing
    • Community Development Finance
    • Corporate & Finance
    • Cybersecurity & Privacy
    • Environmental
    • Franchising & Distribution
    • Government Investigations & White Collar Defense
    • Healthcare
    • Intellectual Property
    • International Services
    • Labor & Employment
    • Litigation
    • Private Wealth & Advisory
    • Project Finance
    • Public Finance
    • Real Estate
    • Regulatory & Government Relations

    Industries

    View All

    • Cannabis
    • Consumer
    • Energy
    • Entertainment
    • Financial Services
    • Healthcare
    • Higher Education
    • Infrastructure
    • Manufacturing
    • Non Profit
    • Real Estate
    • Technology

    Value-Added Services

    View All

    • Alternative Fee Arrangements

      Developing innovative pricing structures and alternative fee agreement models that deliver additional value for our clients.

    • Continuing Education

      Advancing professional knowledge and offering credits for attorneys, staff and other professionals.

    • Crisis Advisory

      Helping clients respond correctly when a crisis occurs.

    • DEI Strategic Services

      Providing our clients with legal, strategic, and practical advice to make transformational changes in their organizations.

    • eDiscovery

      Leveraging law and technology to deliver sound solutions.

    • Global Services

      Delivering seamless service through partnerships across the globe.

    • Innovation

      Leveraging leading-edge technology to guide change and create seamless, collaborative experiences for clients and attorneys.

    • IPED

      Industry-leading conferences focused on affordable housing, tax credits, and more.

    • Legal Project Management

      Providing actionable information to support strategic decision-making.

    • Legally Green

      Teaming with clients to advance sustainable projects, mitigate the effects of climate change, and protect our planet.

    • Nixon Peabody Trust Company

      Offering a range of investment management and fiduciary services.

    • NP Capital Connector

      Bringing together companies and investors for tomorrow’s new deals.

    • NP Second Opinion

      Offering fresh insights on cases that are delayed, over budget, or off-target from the desired resolution.

    • NP Trial

      Courtroom-ready lawyers who can resolve disputes early on clients’ terms or prevail at trial before a judge or jury.

    • Social Impact

      Creating positive impact in our communities through increasing equity, access, and opportunity.

    1. Home
    2. People
    3. Linda B. HuberPeople
    1. Home
    2. People
    3. Linda B. HuberPeople

    Linda B. Huber

    Partner


    • Los Angeles
    • Office213.629.6163
    • lhuber@nixonpeabody.com
    • Download vCard
    • Share
    • LinkedIn Profile

    Introduction

    Linda Huber uses her biochemistry background and patent experience to represent medical and academic institutions, private foundations and medical device and pharmaceutical companies in intellectual property matters.

    Practice Areas

    Intellectual PropertyLife Sciences

    Industries

    Higher EducationHealthcare Industry

    My focus

    I focus on prosecuting biotechnology and life sciences patents, counseling clients on their patent portfolios and prosecution strategies, conducting due diligence of patent portfolios in corporate transactions and patent license agreements and advising clients on patent related license provisions.

    Patent Prosecution

    Particular areas I focus on include cancer therapeutics, gastrointestinal diseases, diagnostics, gene therapy, stem cells, inflammatory conditions, neurological diseases, and nutritional products.

    Client Counseling

    Through my understanding of my clients’ needs and goals, I develop and implement strategies to strengthen, manage and expand their patent portfolios. I also help them understand the implications of licensing terms.

    Looking ahead

    Even with the current jurisprudence on subject matter eligibility, I see that strong patent protection can still be achieved by covering the technology via different angles. Academic institutions and companies, having a strategic patent prosecution plan, should not be deterred from pursuing patent protection for their innovations.

    Presentations and Publications

    • “Legal Essentials for Life Sciences Entrepreneurs: What early-stage founders need to know to scale and safeguard their companies,” Biocom California's Capital Connect: Virtual Investor Roadshow, February 17, 2022
    • “Protecting your work at USC: An Intro to Patents,” USC Michelson Center for Convergent Bioscience, Los Angeles, CA, March 8, 2021
    • “IP Law Roundtable Discussion,” Graduate Women in Science LA, Across the STEMverse, Los Angeles, CA, February 27, 2021
    • “AI in Life Sciences - IP Considerations,” USC Stevens Seminar Series, University of Southern California, Los Angeles, CA, February 19, 2020 and February 20, 2020
    • “Future Forum: Space Commercialization,” Los Angeles County Economic Development Corporation, January 22, 2020
    • “Patent Process,” Patent & Pizza Educational Series at Cedars-Sinai Medical Center, Los Angeles, CA, May 8, 2018
    • “Great Expectations: Managing Faculty and Inventors,” 2017 AUTM Western Region Meeting, Santa Clara, CA, October 12, 2017
    • “Patent Basics,” Patent & Pizza Educational Series at Cedars-Sinai Medical Center, Los Angeles, CA, June 13, 2017
    • “US Best Practices in Patent Filing & Prosecution,” Presentation to Imperial Innovations, London, UK, May 16, 2017
    • “Cost Strategies for European and U.S. Patent Prosecution,” Biocom Lunch & Learn at Nixon Peabody, Los Angeles, CA, May 1, 2017
    • “The New World in US Biotech,” The Chartered Institute of Patent Attorneys Webinar, March 2016
    • “Biotech Claims Drafting,” The Chartered Institute of Patent Attorneys Seminar, London, UK, October 2014
    • “License Lessons: Don’t overlook key elements in patent-related licensing agreements,” GC California, Nov./Dec. 2009. (Co-author)

    Representative experience

    • Represented Cedars-Sinai Medical Center in prosecuting, licensing, and enforcing patent rights on methods of treating irritable bowel syndrome (“IBS”), a chronic condition affecting more than 15% of the general population. Cedars-Sinai doctors invented groundbreaking treatments for IBS, and the NP team helped Cedars-Sinai patent these discoveries and license them to Salix Pharmaceuticals, a wholly-owned subsidiary of Bausch Health Companies Inc. After Actavis Laboratories FL, Inc. sought FDA approval to market a generic competitor drug, NP represented Cedars-Sinai in litigation with its licensees against the infringing generic competitor. That litigation recently was resolved under confidential terms that assure Cedars-Sinai’s patent rights will be protected through their expiration.

    Admitted to practice

    California
    U.S. Patent and Trademark Office

    Education

    University of California, Los Angeles, B.S., Biochemistry
    University of San Diego School of Law, J.D., cum laude

    News Mentions

    • Law360

      Law360 names attys who moved up the firm ranks in Q1

      This article mentions recent leadership promotions at the firm including David Brown, Jared Lusk, Jim Vallee, Graham Beck, Kathleen Ceglarski Burns, Emily Crandall Harlan, Daniel Gibbons, Linda Huber, Ilana Kameros, Haydon Keitner, Darren Miller, Neal Pandozzi, Edward Puerta, Stephen Reil, and Elizabeth Young.
      April 28, 2017

    Insights And Happenings

    • Alert

      Antibody patenting in light of Amgen v. Sanofi

      Jan 25, 2019

    Professionals in the Practice Area

    View All
    • Seth D. Levy

      Partner / Leader, Intellectual Property Practice / Co-chair, Life Sciences Practice
      • Los Angeles
      • Office:213.629.6161
      • slevy@nixonpeabody.com
      Seth D. Levy
    • Ravinderjit Braich, Ph.D.

      Counsel
      • Boston
      • Office:617.345.1089
      • rbraich@nixonpeabody.com
      Ravinderjit Braich, Ph.D.
    • Jennette W. Psihoules

      Associate
      • washington-dc
      • Office:202.585.8385
      • jpsihoules@nixonpeabody.com
      Jennette W. Psihoules
    • Janet M. Garetto

      Partner
      • Chicago
      • Office:312.425.8514
      • jgaretto@nixonpeabody.com
      Janet M. Garetto
    • Andrew Y. Choung

      Partner
      • Los Angeles
      • Office:213.629.6166
      • achoung@nixonpeabody.com
      Andrew  Y. Choung
    View All

    Subscribe to stay informed of the latest legal news, alerts, and business trends.Subscribe

    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    • © 2023 Nixon Peabody. All rights reserved
    • Privacy Policy
    • Terms of Use
    • Statement of Client Rights
    • Supplier Diversity Program
    • Nixon Peabody International LLC
    • PAL